Cargando…
Compound screen identifies the small molecule Q34 as an inhibitor of SARS-CoV-2 infection
The COVID-19 outbreak poses a serious threat to global public health. Effective countermeasures and approved therapeutics are desperately needed. In this study, we screened a small molecule library containing the NCI-DTP compounds to identify molecules that can prevent SARS-CoV-2 cellular entry. By...
Autores principales: | Cui, Qi, Garcia, Gustavo, Zhang, Mingzi, Wang, Cheng, Li, Hongzhi, Zhou, Tao, Sun, Guihua, Arumugaswami, Vaithilingaraja, Shi, Yanhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704726/ https://www.ncbi.nlm.nih.gov/pubmed/34977495 http://dx.doi.org/10.1016/j.isci.2021.103684 |
Ejemplares similares
-
Comparative transcriptomic analysis of SARS-CoV-2 infected cell model systems reveals differential innate immune responses
por: Sun, Guihua, et al.
Publicado: (2021) -
ApoE-Isoform-Dependent SARS-CoV-2 Neurotropism and Cellular Response
por: Wang, Cheng, et al.
Publicado: (2021) -
Structure-based design of antisense oligonucleotides that inhibit SARS-CoV-2 replication
por: Li, Yan, et al.
Publicado: (2021) -
Cold atmospheric plasma for SARS-CoV-2 inactivation
por: Chen, Zhitong, et al.
Publicado: (2020) -
The Apolipoprotein E neutralizing antibody inhibits SARS‐CoV‐2 infection by blocking cellular entry of lipoviral particles
por: Cui, Qi, et al.
Publicado: (2023)